BETHLEHEM, Pa., June 2 /PRNewswire/ -- B. Braun Medical Inc. announces the construction of a new infusion technology facility at the company's global headquarters in Melsungen, Germany.
Known as Avitum Village, the new, five-building, 77 million euro B. Braun manufacturing campus includes a plant dedicated to producing infusion pumps as well as facilities for research and development, services and training. With an initial capacity of an estimated more than 207,000 pumps per year, the new facility is designed to meet an expanding world-wide demand for B. Braun's SPACE Infusion Systems.
"This is a unique business campus that is completely devoted to the development, manufacture and support of infusion devices," said Gale White, Vice President of Infusion Systems Marketing for B. Braun Medical Inc. "It will enable us to meet the increasing demand for high-quality syringe and large volume infusion pumps today and well into the future."
White said demand for B. Braun's SPACE Infusion Systems has expanded dramatically as hospitals and healthcare professionals look for safe, easy-to-use and reliable infusion pumps that can help them provide high-quality patient care, reduce medication errors and enhance their practice and productivity.
Designed with both adult and pediatric facilities in mind, the small, lightweight SPACE Infusion System allows for flexibility and easy transport within a number of care settings. At 9 inches by 6 inches and weighing only three pounds, the SPACE infusion syringe and large volume pumps can fit easily into a range of environments. The system, designed for higher acuity care facilities, offers a large drug library as well as the capability to stack up to 24 pumps in a single bedside tower.
About B. Braun
B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.
Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, email us at firstname.lastname@example.org or visit B. Braun at www.bbraunusa.com.
SOURCE B. Braun Medical Inc.